Litcius/Paper detail

Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer

Akira Inoue, Frederick S. Robinson, Rosalba Minelli, Hideo Tomihara, Bahar Salimian Rizi, Johnathon L. Rose, Takahiro Kodama, Sanjana Srinivasan, Angela L. Harris, Andy M. Zuniga, Robert A. Mullinax, Xiaoyan Ma, Sahil Seth, Joseph R. Daniele, Michael Peoples, Sara Loponte, Kadir C. Akdemir, Tin Oo Khor, Ningping Feng, Jason Roszik, Mary Sobieski, David Brunell, Clifford Stephan, Virginia Giuliani, Angela K. Deem, Takashi Shingu, Yonathan Lissanu Deribe, David G. Menter, Timothy P. Heffernan, Andrea Viale, Christopher A. Bristow, Scott Kopetz, Giulio Draetta, Giannicola Genovese, Alessandro Carugo

2021Gastroenterology39 citationsDOIOpen Access PDF

Topics & Concepts

Colorectal cancerSynthetic lethalityCancerCancer researchTranscriptomeDNA damageMedicineMutationFunctional genomicsMutantPharmacologyBioinformaticsGeneBiologyInternal medicineGenomicsDNAGene expressionGeneticsGenomeNuclear Structure and FunctionGenetic factors in colorectal cancerCell death mechanisms and regulation